Description: Khiron Life Sciences Corp, formerly Adent Capital Corp, is a Canada-based company engaged in alternative medicine sector. The Company is an integrated medical cannabis company with its core operations in Latin America. Khiron is active in the research area in medical cannabis industry. It develops and commercializes medical cannabis products mainly in Colombia.
Home Page: khiron.ca
KHRN Technical Analysis
500 Burrard Street
Vancouver,
BC
V6C 2B5
Canada
Phone:
705 527 3564
Officers
| Name | Title |
|---|---|
| Dr. Alvaro Francisco Torres | Co-Founder, CEO & Director |
| Ms. Franziska Katterbach | Pres of Khiron Europe |
| Mr. Swapan Kakumanu ACA, ACWA, CGA | Corp. Sec. |
| Ms. Helen Bellwood A.C.A. | Interim Chief Financial Officer |
| Mr. Manuel Buendia | VP of Operations |
| Mr. Luis Chavez | Country Mang. of Mexico |
| Mr. Marco Algorta | Country Mang. of Uruguay |
| Mr. Juan Diego Alvarez | VP of Regulations |
Exchange: V
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4391 |
| Price-to-Sales TTM: | 0.7375 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |